Literature DB >> 21725088

N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) triggers MSH2 and Cdt2 protein-dependent degradation of the cell cycle and mismatch repair (MMR) inhibitor protein p21Waf1/Cip1.

Thomas Jascur1, Rati Fotedar, Serena Greene, Erin Hotchkiss, C Richard Boland.   

Abstract

p21(Waf1/Cip1) protein levels respond to DNA damage; p21 is induced after ionizing radiation, but degraded after UV. p21 degradation after UV is necessary for optimal DNA repair, presumably because p21 inhibits nucleotide excision repair by blocking proliferating cell nuclear antigen (PCNA). Because p21 also inhibits DNA mismatch repair (MMR), we investigated how p21 levels respond to DNA alkylation by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), which triggers the MMR system. We show that MNNG caused rapid degradation of p21, and this involved the ubiquitin ligase Cdt2 and the proteasome. p21 degradation further required MSH2 but not MLH1. p21 mutants that cannot bind PCNA or cannot be ubiquitinated were resistant to MNNG. MNNG induced the formation of PCNA complexes with MSH6 and Cdt2. Finally, when p21 degradation was blocked, MNNG treatment resulted in reduced recruitment of MMR proteins to chromatin. This study describes a novel pathway that removes p21 to allow cells to efficiently activate the MMR system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21725088      PMCID: PMC3190993          DOI: 10.1074/jbc.M111.221341

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct.

Authors:  D R Duckett; J T Drummond; A I Murchie; J T Reardon; A Sancar; D M Lilley; P Modrich
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis.

Authors:  A Umar; A B Buermeyer; J A Simon; D C Thomas; A B Clark; R M Liskay; T A Kunkel
Journal:  Cell       Date:  1996-10-04       Impact factor: 41.582

3.  Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  J M Carethers; M T Hawn; D P Chauhan; M C Luce; G Marra; M Koi; C R Boland
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

4.  Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6.

Authors:  A Umar; M Koi; J I Risinger; W E Glaab; K R Tindall; R D Kolodner; C R Boland; J C Barrett; T A Kunkel
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

5.  Proteasome-dependent regulation of p21WAF1/CIP1 expression.

Authors:  M V Blagosklonny; G S Wu; S Omura; W S el-Deiry
Journal:  Biochem Biophys Res Commun       Date:  1996-10-14       Impact factor: 3.575

6.  The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA.

Authors:  S Waga; G J Hannon; D Beach; B Stillman
Journal:  Nature       Date:  1994-06-16       Impact factor: 49.962

7.  Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts.

Authors:  M Pagano; A M Theodoras; S W Tam; G F Draetta
Journal:  Genes Dev       Date:  1994-07-15       Impact factor: 11.361

8.  A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen.

Authors:  E Warbrick; D P Lane; D M Glover; L S Cox
Journal:  Curr Biol       Date:  1995-03-01       Impact factor: 10.834

9.  Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer.

Authors:  N de Wind; M Dekker; A Berns; M Radman; H te Riele
Journal:  Cell       Date:  1995-07-28       Impact factor: 41.582

10.  MSH2-MSH6 stimulates DNA polymerase eta, suggesting a role for A:T mutations in antibody genes.

Authors:  Teresa M Wilson; Alexandra Vaisman; Stella A Martomo; Patsa Sullivan; Li Lan; Fumio Hanaoka; Akira Yasui; Roger Woodgate; Patricia J Gearhart
Journal:  J Exp Med       Date:  2005-02-14       Impact factor: 14.307

View more
  16 in total

1.  A novel function of CRL4(Cdt2): regulation of the subunit structure of DNA polymerase δ in response to DNA damage and during the S phase.

Authors:  Sufang Zhang; Hong Zhao; Zbiegniew Darzynkiewicz; Pengbo Zhou; Zhongtao Zhang; Ernest Y C Lee; Marietta Y W T Lee
Journal:  J Biol Chem       Date:  2013-08-02       Impact factor: 5.157

2.  Mismatch repair regulates Cdt1 after UV damage.

Authors:  Andreas Panagopoulos; Stavros Taraviras; Zoi Lygerou
Journal:  Cell Cycle       Date:  2017-06-18       Impact factor: 4.534

3.  Mismatch repair proteins recruited to ultraviolet light-damaged sites lead to degradation of licensing factor Cdt1 in the G1 phase.

Authors:  Miyuki Tanaka; Michiyo Takahara; Kohei Nukina; Akiyo Hayashi; Wataru Sakai; Kaoru Sugasawa; Yasushi Shiomi; Hideo Nishitani
Journal:  Cell Cycle       Date:  2017-02-22       Impact factor: 4.534

4.  Cancer stem cell-associated miRNAs serve as prognostic biomarkers in colorectal cancer.

Authors:  Shusuke Toden; Shigeyasu Kunitoshi; Jacob Cardenas; Jinghua Gu; Elizabeth Hutchins; Kendall Van Keuren-Jensen; Hiroyuki Uetake; Yuji Toiyama; Ajay Goel
Journal:  JCI Insight       Date:  2019-03-21

5.  Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression.

Authors:  Kazuhiro Yoshida; Shusuke Toden; Preethi Ravindranathan; Haiyong Han; Ajay Goel
Journal:  Carcinogenesis       Date:  2017-10-01       Impact factor: 4.944

6.  Novel Evidence for Curcumin and Boswellic Acid-Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer.

Authors:  Shusuke Toden; Yoshinaga Okugawa; Constanze Buhrmann; Durgha Nattamai; Esperanza Anguiano; Nicole Baldwin; Mehdi Shakibaei; C Richard Boland; Ajay Goel
Journal:  Cancer Prev Res (Phila)       Date:  2015-02-23

7.  Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.

Authors:  Shusuke Toden; Yoshinaga Okugawa; Thomas Jascur; Dominik Wodarz; Natalia L Komarova; Constanze Buhrmann; Mehdi Shakibaei; C Richard Boland; Ajay Goel
Journal:  Carcinogenesis       Date:  2015-02-04       Impact factor: 4.944

8.  p53 activation by Cr(VI): a transcriptionally limited response induced by ATR kinase in S-phase.

Authors:  Michal W Luczak; Casey Krawic; Anatoly Zhitkovich
Journal:  Toxicol Sci       Date:  2019-08-06       Impact factor: 4.849

9.  A comprehensive in vivo and mathematic modeling-based kinetic characterization for aspirin-induced chemoprevention in colorectal cancer.

Authors:  Tadanobu Shimura; Shusuke Toden; Natalia L Komarova; Crichard Boland; Dominik Wodarz; Ajay Goel
Journal:  Carcinogenesis       Date:  2020-07-10       Impact factor: 4.944

10.  A simple and reproducible breast cancer prognostic test.

Authors:  Luigi Marchionni; Bahman Afsari; Donald Geman; Jeffrey T Leek
Journal:  BMC Genomics       Date:  2013-05-17       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.